A role for tumor necrosis factor-α in remodeling the splenic marginal zone during Leishmania donovani infection

American Journal of Pathology

Volumn 161, Issue 2, 2002, Pages 429-437

  Engwerda, Christian R ^a   Ato, Manabu ^a   Cotterell, Sara E J ^a   Mynott, Tracey L ^b   Tschannerl, Asiya ^a   Gorak Stolinska, Patricia M A ^a   Kaye, Paul M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; FAS LIGAND; STIBOGLUCONATE SODIUM; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; LEISHMANIA DONOVANI; LEISHMANIASIS; LYMPHOID TISSUE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL;

EID: 0036965939     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64199-5     Document Type: Article

References (59)

1. Kraal G: Cells in the marginal zone of the spleen. Int Rev Cytol 1992, 132:31-74
2. Van Vliet E, Melis M, Foidart JM, Van Ewijk W: Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody. J Histochem Cytochem 1986, 34:883-890
3. Lyons AB, Parish CR: Are murine marginal-zone macrophages the splenic white pulp analog of high endothelial venules? Eur J Immunol 1995, 25:3165-3172
4. Amlot PL, Grennan D, Humphrey JH: Splenic dependence of the antibody response to thymus-independent (TI-2) antigens. Eur J Immunol 1985, 15:508-512
5. Guinamard R, Okigaki M, Schlessinger J, Ravetch JV: Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 2000, 1:31-36
6. Cyster JG: B cells on the front line. Nat Immunol 2000, 1:9-10
7. Humphrey JH, Grennan D: Different macrophage populations distinguished by means of fluorescent polysaccharides. Recognition and properties of marginal-zone macrophages. Eur J Immunol 1981, 11:221-228
8. Franzoso G, Carlson L, Scharton-Kersten T, Shores EW, Epstein S, Grinberg A, Tran T, Shacter E, Leonardi A, Anver M, Love P, Sher A, Siebenlist U: Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 1997, 6:479-490
9. Poljak L, Carlson L, Cunningham K, Kosco-Vilbois MH, Siebenlist U: Distinct activities of p52/NF-kappa B required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3. J Immunol 1999, 163:6581-6588
10. Korner H, Cook M, Riminton DS, Lemckert FA, Hoek RM, Ledermann B, Kontgen F, Fazekas de St Groth B, Sedgwick JD: Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol 1997, 27:2600-2609
11. Weih DS, Yilmaz ZB, Weih F: Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol 2001, 167:1909-1919
12. Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K, Siebenlist U: Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 1998, 187:147-159
13. Alexopoulou L, Pasparakis M, Kollias G: A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol 1997, 27:2588-2592
14. Ettinger R, Mebius R, Browning JL, Michie SA, van Tuijl S, Kraal G, van Ewijk W, McDevitt HO: Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development. Int Immunol 1998, 10:727-741
15. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA: Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice Immunity 1997, 6:491-500
16. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS: Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 1996, 184:1999-2006
17. Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, Janatpour MJ, Korner H, Scheerens H, Hessel EM, Cyster JG, McEvoy LM, Sedgwick JD: Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 2001, 15:533-543
18. Pasparakis M, Kousteni S, Peschon J, Kollias G: Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell Immunol 2000, 201:33-41
19. Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL: Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol 1997, 27:2033-2042
20. Zijlstra EE, el-Hassan AM: Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 2001, 95(Suppl 1): S27-S58
21. White NJ: Malaria. Manson’s Tropical Diseases. Edited by GC Cook. London, W. B. Saunders, 1996, pp 1087-1164
22. Weiss L: Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy. Am J Trop Med Hyg 1989, 41:144-160
23. Davis A: Schistosomiasis. Manson’s Tropical Diseases. Edited by GC Cook. London, W B. Saunders, 1996. pp 1413-1456
24. Warren KS: The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg 1972, 66:417-434
25. Alves HJ, Weidanz W, Weiss L: The spleen in murine Plasmodium chabaudi adami malaria: stromal cells, T lymphocytes, and hematopoiesis. Am J Trop Med Hyg 1996, 55:370-378
26. Bryceson ADM: Leishmaniasis, Manson’s Tropical Diseases. Edited by GC Cook. London, W. B. Saunders, 1996, pp 1213-1245
27. Wilson ME, Sandor MB, Young AM, Metwali BM, Elliott A, Lynch D, Weinstock RG: Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J Immunol 1996, 156:2231-2239
28. Smelt SC, Engwerda CR, McCrossen M, Kaye PM: Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol 1997, 158:3813-3821
29. Roths JB, Murphy ED, Eicher EM: A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med 1984, 159:1-20
30. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991, 350:423-426
31. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM: Neutralization of IL-12 demonstrates the existence of discrete organspecific phases in the control of Leishmania donovani. Eur J Immunol 1998, 28:669-680
32. Trotter ER, Peters W, Robinson BL: The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection. Ann Trop Med Parasitol 1980, 74:127-138
33. Sheehan KC, Ruddle NH, Schreiber RD: Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 1989, 142:3884-3893
34. Matsuno K, Fujii H, Kotani M: Splenic marginal-zone macrophages and marginal metallophils in rats and mice. Cell Tissue Res 1986, 246:263-269
35. Kaye PM, Bancroft GJ: Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect Immun 1992, 60:4335-4342
36. Dijkstra CD, Van Vliet E, Dopp EA, van der Lelij AA, Kraal G: Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno- and enzyme-histochemical properties and functional capacities. Immunology 1985, 55:23-30
37. Kraal G, Janse M: Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology 1986, 58:665-669
38. Crocker PR, Gordon S: Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med 1989, 169:1333-1346
39. Gorak PM, Engwerda CR, Kaye PM: Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol 1998, 28:687-695
40. Briskin MJ, McEvoy LM, Butcher EC: MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 1993, 363:461-464
41. Odermatt B, Eppler M. Leist TP, Hengartner H, Zinkernagel RM: Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci USA 1991, 88:8252-8256
42. Engwerda CR, Smelt SC, Kaye PM: An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. Exp Parasitol 1996, 84:195-202
43. Althage A, Odermatt B, Moskophidis D, Kundig T, Hoffman-Rohrer U, Hengartner H, Zinkernagel RM: Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur J Immunol 1992, 22:1803-1812
44. Blackwell JM, Roach TI, Kiderlen A, Kaye PM: Role of Lsh in regulating macrophage priming/activation. Res Immunol 1989, 140:798-805
45. Pathak MK. Yi T: Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol 2001, 167:3391-3397
46. Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW: Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 2000, 68:6289-6293
47. Kanaly ST, Nashleanas M, Hondowicz B, Scott P: TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. J Immunol 1999, 163:3883-3889
48. Schett G, Hayer S. Tohidast-Akrad M, Schmid BJ, Lang S, Turk B, Kainberger F, Haralambous S, Kollias G, Newby AC, Xu Q, Steiner G, Smolen J: Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice. Arthritis Rheum 2001, 44:2888-2898
49. Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, Mann DL: Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001, 104:826-831
50. van Rooijen N, Kors N, Kraal G: Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J Leukoc Biol 1989, 45:97-104
51. Cotterell SE, Engwerda CR, Kaye PM: Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani. Infect Immun 2000, 68:1840-1848
52. Murray HW, Oca MJ, Granger AM, Schreiber RD: Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. J Clin Invest 1989, 83:1253-1257
53. Cillari EV, Arcoleo G, D’Agostino F, Mocciaro P, Gambino C, Malta G, Stassi R, Giordano G, Milano CS: in vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis Cytokine 1995, 7:740-745
54. Alexander CE, Kaye PM, Engwerda CR: CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur J Immunol 2001, 31:1199-1210
55. Garside P, Ingulli E. Merica RR, Johnson JG, Noelle RJ, Jenkins MK: Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998, 281:96-99
56. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712
57. Barral-Netto M, Badaro R, Barral A, Almeida RP, Santos SB, Badaro F, Pedral-Sampaio D, Carvalho EM, Falcoff E, Falcoff R: Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis 1991, 163:853-857
58. Raziuddin S, Abdalla RE, el-Awad EH, al-Janadi M: Immunoregulatory and proinflammatory cytokine production in visceral and cutaneous leishmaniasis J Infect Dis 1994, 170:1037-1040
59. Morsy TA, el Missiry AG, Sarwat MA, el Rassed MM, Habib FS, Abou Gamra MM: Tumour necrosis factor-alpha (cachectin) in human visceral leishmaniasis. J Egypt Soc Parasitol 1995, 25:31-51